NL8303211A - Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. - Google Patents

Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. Download PDF

Info

Publication number
NL8303211A
NL8303211A NL8303211A NL8303211A NL8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A
Authority
NL
Netherlands
Prior art keywords
cisplatinum
sterile
lyophilized
product
stable
Prior art date
Application number
NL8303211A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8303211A publication Critical patent/NL8303211A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NL8303211A 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. NL8303211A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
IT2339682 1982-09-23

Publications (1)

Publication Number Publication Date
NL8303211A true NL8303211A (nl) 1984-04-16

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303211A NL8303211A (nl) 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.

Country Status (20)

Country Link
US (1) US4670262A (da)
JP (1) JPS5978117A (da)
AT (1) AT382077B (da)
AU (1) AU559499B2 (da)
BE (1) BE897761A (da)
CA (1) CA1211372A (da)
CH (1) CH655852A5 (da)
DE (1) DE3333024A1 (da)
DK (1) DK157168C (da)
FI (1) FI78236C (da)
FR (1) FR2533439B1 (da)
GB (1) GB2127291B (da)
GR (1) GR79055B (da)
IE (1) IE56173B1 (da)
IL (1) IL69752A (da)
IT (1) IT1153974B (da)
NL (1) NL8303211A (da)
SE (1) SE464061B (da)
SU (1) SU1424722A3 (da)
ZA (1) ZA836904B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
CA2122342A1 (en) * 1992-09-04 1994-03-17 Hironori Kawabata Pharmaceutical composition
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE363910T1 (de) * 1999-11-15 2007-06-15 Pharma Mar Sa Behandlung von krebserkrankungen durch aplidin
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
BR0114604A (pt) * 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
AU2002243646B2 (en) 2001-01-25 2006-06-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
WO2003026642A1 (fr) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Preparation pharmaceutique lyophilisee
PT1435991E (pt) * 2001-10-19 2009-01-16 Pharma Mar Sa Utilização de aplidina para o tratamento de cancro pancreático
KR20060002778A (ko) * 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
AU2004218883B2 (en) * 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
DE50305909D1 (de) * 2003-10-13 2007-01-18 Salama Zoser B Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
ES2575518T3 (es) * 2006-02-28 2016-06-29 Pharma Mar S.A. Tratamiento mejorado de mieloma múltiple
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CN101965191A (zh) * 2008-03-07 2011-02-02 法马马有限公司 改善的抗癌治疗
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) * 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
CA1162479A (en) * 1980-03-31 1984-02-21 Murray A. Kaplan Pharmaceutical formulations containing cisplatin

Also Published As

Publication number Publication date
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
IT8223396A0 (it) 1982-09-23
GB2127291B (en) 1986-01-15
IT1153974B (it) 1987-01-21
FR2533439B1 (fr) 1986-08-14
AT382077B (de) 1987-01-12
FI833300A0 (fi) 1983-09-15
BE897761A (fr) 1984-01-02
FI78236B (fi) 1989-03-31
IL69752A (en) 1986-07-31
DK424383D0 (da) 1983-09-16
AU559499B2 (en) 1987-03-12
ZA836904B (en) 1984-10-31
GB2127291A (en) 1984-04-11
IL69752A0 (en) 1983-12-30
FR2533439A1 (fr) 1984-03-30
SE8304920D0 (sv) 1983-09-13
ATA326283A (de) 1986-06-15
GB8324380D0 (en) 1983-10-12
FI78236C (fi) 1989-07-10
SE8304920L (sv) 1984-03-24
IE56173B1 (en) 1991-05-08
SE464061B (sv) 1991-03-04
JPS5978117A (ja) 1984-05-04
DK157168B (da) 1989-11-20
DK157168C (da) 1990-04-09
CA1211372A (en) 1986-09-16
IE832172L (en) 1984-03-23
DE3333024A1 (de) 1984-03-29
DK424383A (da) 1984-03-24
AU1908983A (en) 1984-03-29
CH655852A5 (de) 1986-05-30
FI833300A (fi) 1984-03-24
GR79055B (da) 1984-10-02

Similar Documents

Publication Publication Date Title
NL8303211A (nl) Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.
JPH0313174B2 (da)
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
JPH05331071A (ja) カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
EP2887953B1 (en) Improved daptomycin injectable formulation
RU2362557C2 (ru) Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение
KR860000841B1 (ko) 시스프라틴의 안정화된 농축용액의 제조방법
CN101991857B (zh) 稳定型药物制剂及其制备方法
KR101487953B1 (ko) 유기용매 무함유 젬시타빈 수용액 조성물
JPS5938207B2 (ja) 腎疾患治療剤
JPS61197527A (ja) インタ−ロイキン−２組成物
CN1074278C (zh) 前列腺素e1无菌冻干粉针剂生产工艺
RU2096043C1 (ru) Антигипоксическое средство и способ его получения
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
RU2504376C1 (ru) Высокостабильный фармацевтический состав на основе лиофилизата производных 3-оксипиридинов, или метилпиридинов, или их фармацевтически приемлемых солей
Hrubiško et al. Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump
JP2770571B2 (ja) 安定化された注射剤および注射剤の安定化法
EP1691813B1 (en) Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals;
KR950010149B1 (ko) 5-클로로-1-[1-{3-(2,3-디하이드로-2-옥소-1h-벤즈이미다졸-1-열)프로필}-4-피페리딘]-1,3-디하이드로-2h-벤즈이미다졸-2-온(돔페리돈) 액제의 제조방법
RU2199321C1 (ru) Смесевая лекарственная форма на основе фторпиримидинового антиметаболита и способ ее получения
JP6033931B2 (ja) 有機溶媒無含有ゲムシタビン水溶液組成物
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
WO2018142514A1 (ja) ダルベポエチンを含む液体医薬組成物
EP1663106A2 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
RU97119749A (ru) Способ лечения рака мочевого пузыря

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ERBAMONT INDUSTRIALE S.R.L.

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ERBA S.R.L. FARMITALIA CARLO -

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed